Sagent Pharma Raises $40 Million
Sagent Pharmaceuticals Inc., a Schaumburg, Ill.-based developer of injectible drugs, has raised $40 million in Series B funding. Zhejiang Hisun Pharmaceutical Co. Ltd.provided $10 million, while the remainder came from an undisclosed China-docused private equity fund. The firm previously raised over $110 million in VC funding from firms like Vivo Ventures.
9 April 2010•2 mins read
